Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.4 EUR | +8.43% | +5.88% | -16.92% |
2023 | Noratis AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Noratis AG Announces Board Changes | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company's share price in relation to its net book value makes it look relatively cheap.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- Low profitability weakens the company.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- Based on current prices, the company has particularly high valuation levels.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Real Estate Development & Operations
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-16.92% | 41.57M | - | ||
-4.77% | 23.68B | A- | ||
-29.16% | 11.19B | B+ | ||
+8.63% | 10.77B | - | B- | |
-25.90% | 7.53B | - | B+ | |
-5.56% | 7.03B | C- | ||
-0.34% | 6.54B | C+ | ||
+0.76% | 6.33B | A- | ||
+14.08% | 3.64B | - | ||
-5.23% | 3.59B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- NUVA Stock
- Ratings Noratis AG